TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT02743819

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Pembrolizumab given every 3 weeks (200 mg) by IV infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ipilimumab
Description: Ipilimumab given every 3 weeks (200 mg) by IV infusion for total of 4 doses.
Study: NCT02862860

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: blood sample

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: blood sample

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: urine sample

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: urine sample

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: installation of Holter
Study: NCT00288353

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: aripiprazole (Abilify)
Description: active drug given daily as per package insert according to standard clinical care for twelve month duration of study. Subject will be switched from current antipsychotic to this drug or other randomized study medication.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ziprasidone (Geodon)
Description: active medication will be given daily as per package insert according to standard clinical care for the twelve month duration of the study. Subject will be switched from current antipsychotic medication to this medication or the other randomized medication.
Study: NCT02801903

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SB204 4%
Description: Topically Once Daily (AM)
Study: NCT01891435

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oral paracetamol
Description: after giving medicine temperature is checked every 30 minutes for 2 hours

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Intravenous paracetamol
Description: after giving medicine temperature is checked every 30 minutes for 2 hours

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Intramuscular diclofenac
Description: after giving medicine temperature is checked every 30 minutes for 2 hours
Study: NCT03783546

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Acupuncture
Description: Acupuncture is a complementary therapy in which, hair-thin, sterile disposable needles are inserted into various spots on your skin, with the goal of affecting body's natural healing system

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: the current standard of care with non-hormonal pharmacotherapy of western medicine
Study: NCT00647751

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lamotrigine Tablets 25 mg
Description: 2x25mg, single dose fed

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lamictal® Tablets 25 mg
Description: 2x25mg, single dose fed
Study: NCT04158596

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Vibration Therapy
Description: SDX-3101 is used for drug-free treatment of CRSsNP in adults.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Vibration Therapy
Description: SDX-3101 is used for drug-free treatment of CRSsNP in adults.
Study: NCT02642484

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Gabapentin
Description: Gapapentin twice daily

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Calcium Carbonate
Description: calcium carbonate twice daily
Study: NCT03675672

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Misoprostol Oral Tablet
Description: Misoprostol 200mcg

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Oral Tablet
Description: Placebo Tablet
Study: NCT03159741

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Inhibitor + GLP-2
Description: Inhibitor and GLP-2 are used as study tools.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo + GLP-2
Description: Placebo and GLP-2 are used as study tools.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Placebo + GIP
Description: Placebo and GIP are used as study tools.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo + Saline
Description: Placebo
Study: NCT00906919

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Regular diabetes patient education
Description: Professionally-led diabetes patient education delivered by health professionals over a two day period

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Augmented diabetes patient education
Description: Professionally-led diabetes patient education led by nurse and dietitian over a two day period augmented by participation in the Stanford Chronic Disease Self-Management Program. This program takes place for 2 1/2 hours per week for six consecutive weeks.
Study: NCT01337804

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: omeprazole/sodium bicarbonate
Description: Single 20 mg dose of omeprazole/sodium bicarbonate powder for oral suspension

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: omeprazole/sodium bicarbonate
Description: Single 20 mg dose of omeprazole/sodium bicarbonate powder for oral suspension

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: omeprazole magnesium
Description: Single 40 mg capsule of omeprazole given orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: omeprazole magnesium
Description: Single 40 mg capsule of omeprazole given orally
Study: NCT03977662

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Co-transplantation of PTG with pancreatic islets
Description: Co-transplantation of allogeneic parathyroid glands (PTG) with adult pancreatic islets (both PTG and pancreatic islets obtained from same deceased donor) in people with Type 1 diabetes in the intramuscular (IM) site with stable function of liver or kidney allografts on chronic immunosuppression
Study: NCT02535663

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: RG
Description: The 100mg Korean citrus Hallabong peel polysaccharide contained 60mg rhamnogalacturonan (RG), 20mg mono- and di-saccharide, 5mg polyphenol, 5mg ash and 10mg moisture

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Same product without RG
Study: NCT02211144

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BIBR 796 BS

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study: NCT01301820

Intervention type: DRUG
Group type: OTHER
Intervention: azacitidine
Description: azacitidine sc 75 mg/m²/d (d1- d7)

Intervention type: DRUG
Group type: OTHER
Intervention: Lenalidomide
Description: lenalidomide 10mg/d (d1- d21)
Study: NCT02207270

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Same day discharge
Description: Patients randomized to SDD will be discharged home on the day of their PCI, at least 6 hours following its completion. They will receive a follow up phone call from a study coordinator the next day and at 30 days to ascertain what costs (if any) were accrued and whether any adverse outcomes occurred.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Overnight Stay
Description: Patients who experienced uncomplicated PCI, as well as an uncomplicated 6-hour observation period, will be randomly assigned to an overnight stay, generally considered standard or routine care. Patients randomized to overnight stay will be discharged the following morning to receive a follow up phone call at 30 days to ascertain what costs (if any) were accrued and whether any adverse outcomes occurred.
Study: NCT04071795

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Opt-Out Reminder
Description: half will receive a clinical reminder that includes a standing NRT order and a referral to cessation counseling that will automatically generate unless the provider actively opts-out

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Opt-In Reminder
Description: Half of the psychiatrists will receive a reminder that encourages the psychiatrist to offer cessation medications and referral to cessation counseling to patients interested in quitting
Study: NCT00931333

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: non percutaneous vertebroplasty
Description: The patient will undergo general anaesthetic. With a low invasive approach, 4 screws will be placed in pedicles of vertebra under and above the fractured vertebra. The reduction of the fracture will be realised by a smooth movement, and screws positions will be verified by a radio control, with a guided navigation system. The stems will be placed and locked. After the screw positioning, the fractured vertebra pedicles will be reached by a low invasive approach, using a 6 mm trocar, to raise, if necessary, the vertebral plate. Then the cement will be injected in the vertebral body, under radio control. When the maximal volume (6 to 8 ml) is reached, or if an extra vertebral leak is detected, the cement injection is stopped. Then the incision is closed. The next day, the patient will be placed in a corset for a 2 months period.
Study: NCT00438347

Intervention type: BEHAVIORAL
Intervention: Aerobic Exercise
Description: One hour per day three times a week for one year

Intervention type: BEHAVIORAL
Intervention: Stretching and toning
Description: One hour per day three times a week for one year
Study: NCT01387230

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK573719
Description: 62.5 mcg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK573719
Description: 125mcg

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study: NCT05332184

Intervention type: PROCEDURE
Intervention: aortic valve surgery
Study: NCT00082745

Intervention type: OTHER
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies

Intervention type: OTHER
Intervention: Questionnaire Administration
Description: Ancillary studies
Study: NCT04271787

Intervention type: OTHER
Intervention: questionnaire
Description: Questionnaire

Intervention type: OTHER
Intervention: questionnaire
Description: Questionnaire

Intervention type: OTHER
Intervention: questionnaire
Description: Questionnaire

Intervention type: OTHER
Intervention: questionnaire
Description: Questionnaire

Intervention type: OTHER
Intervention: questionnaire
Description: Questionnaire

Intervention type: OTHER
Intervention: questionnaire
Description: Questionnaire
Study: NCT01561781

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Digoxin
Description: Oral tablets 0.25mg, single dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vandetanib
Description: Oral tablets, 300 mg, single dose
Study: NCT03730974

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Protac Ball BlanketTM (7kg Flexible)
Description: All patients will wear a MotionLogger Micro Watch from Ambulatory Monitoring Inc. NY in all four weeks during all 24hours of the day.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Protac Ball BlanketTM (7kg Flexible)
Description: All patients will wear a MotionLogger Micro Watch from Ambulatory Monitoring Inc. NY in all four weeks during all 24hours of the day.
Study: NCT02174796

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: surgical treatment
Description: patients who chose to undergo a surgical correction (Ravitch or Nuss type intervention).

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: orthopedic treatment
Description: orthopedic treatment by vacuum bell.
Study: NCT00505869

Intervention type: BEHAVIORAL
Intervention: Health & Wellness Intervention
Description: Counseling focusing on health concerns related to pregnancy, information about smoking and pregnancy, tips for quitting, and problem-solving skills to manage situations that might be triggers for smoking.

Intervention type: BEHAVIORAL
Intervention: Questionnaire
Description: Questionnaires about mood, confidence in quitting, smoking behavior, and social support.

Intervention type: BEHAVIORAL
Intervention: Questionnaire
Description: Questionnaires about mood, confidence in quitting, smoking behavior, and social support.

Intervention type: BEHAVIORAL
Intervention: Mood Management Intervention
Description: Counseling focusing on learning to manage negative moods (depressed mood, tension, anxiety), as well as providing tips for quitting smoking, problem-solving skills, and information about smoking and pregnancy.
Study: NCT03370471

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Retrieval Practice + Moderate Intensity Exercise
Description: Subjects will engage in 30 minutes of moderate-intensity cycling prior to word learning using Retrieval Practice (active retrieval during learning)

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Retrieval Practice + Moderate Intensity Exercise
Description: Subjects will engage in 30 minutes of moderate-intensity cycling prior to word learning using Retrieval Practice (active retrieval during learning)
Study: NCT03782246

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CBT
Description: Cognitive Behavioral Therapy
Study: NCT04114760

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: patchy-type wireless ECG
Description: This device consists of a single patchy and save the ECG result as a Potable Document Format. Also can transfer to hospital using wifi-network.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: defibrillator ECG
Description: This device is essential equipment in ambulance. For 12-lead ECG examination the connector need to replace for specific cable.
Study: NCT00686712

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 1- Insulin glargine QHS
Description: Insulin glargine at bedtime (dose titrated to maintain 50% of fasting glucose readings \<120 mg/dL)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 2 - Insulin glargine QAM
Description: Insulin glargine in AM (dose titrated to maintain 50% of pre-supper glucose readings \<120 mg/dL)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 3 - NPH insulin QHS
Description: NPH insulin at bedtime (dose titrated to maintain 50% of fasting glucoses \<120 mg/dL)
Study: NCT01973764

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Ultrasound guided ventricular drain insertion
Description: Ventricular puncture and insertion of the intraventricular catheter is performed under ultrasound guidance.

Intervention type: PROCEDURE
Group type: OTHER
Intervention: landmark-based ventricular drain insertion
Description: Ventricular puncture and insertion of the intraventricular catheter is performed without any guiding devices and is based on anatomical landmarks.
Study: NCT00949702

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: vemurafenib
Description: 960 mg b.i.d. continuous oral dosing
Study: NCT00514839

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing
Description: Two sessions of Motivational Interviewing (after baseline assessment and 4 weeks later) plus one individualized feedback based on the Transtheoretical Model of Behavior Change (8 weeks after baseline assessment)
Study: NCT00059462

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Interleukin-2 SA
Description: HAART and Bay 50-4798

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: HAART
Description: HAART alone
Study: NCT04119414

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Spear and Shield (S&S) Program
Description: The S\&S Program is a comprehensive sexual risk reduction intervention consisting of 4 weekly 90-minute manualized group sessions conducted by a trained Community Health Center (CHC) facilitator.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Like Father Like Son (LFLS) Program
Description: The LFLS Program is a private 2 90-minute session conducted by a trained CHC facilitator. The sessions will be focused on exploring issues relevant to parental decision making related to voluntary medical male circumcision (VMMC) and early infant male circumcision (EIMC). Session 1 will be conducted antenatal and Session 2 will be immediately post-partum.
Study: NCT02506088

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Your Voice Your View
Description: Session 1 of the intervention involves background information, an introduction to social norms, and bystander intervention skills training. Session 2 of the intervention establishes conditions for consent, types of abusive behavior and identifying abuse. Session 3 of the intervention addresses risk reduction strategies for girls. Session 3 of the intervention addresses false accusations, masculinity, and additional practice on identifying conditions for consent for boys. Session 4 of the intervention includes active practice of bystander intervention skills.
Study: NCT03586154

Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Platelet rich plasma
Description: combined platelet rich plasma and 1 ml ketamine in a dose of o.5 ml/kg plus 5ml bupivacaine 0.5% in a total volume 10 ml

Intervention type: DRUG
Group type: OTHER
Intervention: ketamine and bupivacaine injection
Description: 1 ml ketamine in a dose of o.5 ml/kg plus 5ml bupivacaine 0.5% in a total volume 10 ml

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ketamine and bupivacaine injection
Description: 1 ml ketamine in a dose of o.5 ml/kg plus 5ml bupivacaine 0.5% in a total volume 10 ml
Study: NCT03370471

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Retrieval Practice + Gentle Stretching
Description: Subject will engage in 30 minutes of gentle upper- and lower- limb stretching prior to word learning using Retrieval Practice (active retrieval during learning)

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Retrieval Practice + Gentle Stretching
Description: Subject will engage in 30 minutes of gentle upper- and lower- limb stretching prior to word learning using Retrieval Practice (active retrieval during learning)

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Study Only + Moderate Intensity Exercise
Description: Subjects will engage in 30 minutes of gentle stretching prior to word learning using Study Only (no active retrieval during learning)

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Study Only + Moderate Intensity Exercise
Description: Subjects will engage in 30 minutes of gentle stretching prior to word learning using Study Only (no active retrieval during learning)

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Study Only + Gentle Stretching
Description: Subjects will engage in 30 minutes of gentle stretching prior to word learning using Study Only (no active retrieval during learning)

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Study Only + Gentle Stretching
Description: Subjects will engage in 30 minutes of gentle stretching prior to word learning using Study Only (no active retrieval during learning)
Study: NCT04632472

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Active fixation bipolar lead versus passive fixation quadripolar leads in Cardiac Resynchronization Therapy
Description: Cardiac resynchronization therapy trial comparing types of leads.

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Active fixation bipolar lead versus passive fixation quadripolar leads in Cardiac Resynchronization Therapy
Description: Cardiac resynchronization therapy trial comparing types of leads.
Study: NCT00004239

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Compound 506U78
Study: NCT02083666

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SOBI002
Description: Test Product

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Reference product
Study: NCT06502899

Intervention type: OTHER
Intervention: Cardiac MRI
Description: Patients with a diagnosis of MINOCA and completed CMR were included in this study
Study: NCT03154762

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NIPPV
Description: Application of chronic distension of the airway through NIPPV to produce a reduction in bronchial hyperreactivity.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: CPAP
Description: 4 cmH2O CPAP as the minimum pressure necessary to mobilize the air flow and avoid the space death with no effect on the ventilation.
Study: NCT01581541

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PU-H71
Description: PU-H71 is a synthetic HSP90 inhibitor which can bind both open and closed conformations of HSP90. It demonstrates extended tumor retention and client protein degradation, while being rapidly cleared from normal tissues. It has shown complete tumor responses and retained sensitivity to retreatment in vivo.
Study: NCT00414128

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: mycophenolate mofetil
Description: 2-3g/day for 3-6 months, in tablet, capsule or liquid form

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: cyclophosphamide
Description: intravenous cyclophosphamide, 15mg/kg with dose reductions according to age and renal function, for 3-6 months (6-10 doses total)
Study: NCT02306382

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Perianal abscess drainage
Description: The patientens will be randomly selected and after they have taken part and said yes to the study, half the group will undergo examination with ultrasound and half without. After this random selection all the patients abscess will be drained.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Perianal abscess drainage
Description: The patientens will be randomly selected and after they have taken part and said yes to the study, half the group will undergo examination with ultrasound and half without. After this random selection all the patients abscess will be drained.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 3D ultrasonography
Description: The patientens will be randomly selected and after they have taken part and said yes to the study, half the group will undergo examination with ultrasound and half without. After this random selection all the patients abscess will be drained.